Andrea DiFabio

Andrea DiFabio

Chief Legal Officer and Corporate SecretaryatXenon Pharmaceuticals· In proxies 2022–2025

Pay in FY2023-52% from the year before · Xenon Pharmaceuticals stock +16.8% the same year

Andrea DiFabio was paid $1.7M in FY2023 (Dec), down 52%. Xenon Pharmaceuticals stock rose 16.8% that year.

Pay$100 in the stock at the end of FY21 → $147
Pay is from the Summary Compensation Table of each Xenon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Xenon PharmaceuticalsPublic company · 4 yr
    • Chief Legal Officer and Corporate Secretary2022 – Present · 4 yrStock in role +16%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?